Healthtech startup Temple, founded by Deepinder Goyal, has doubled its valuation through a secondary share sale while opening its first employee liquidity programme
Healthtech startup Temple, founded by Deepinder Goyal, has doubled its valuation to USD 375 million following a secondary share sale and has launched its first employee stock ownership plan (ESOP) liquidity programme, according to media reports.
The secondary transaction values the company at nearly twice its previous valuation of USD 190 million. Temple had earlier raised USD 54 million at the previous valuation.
In a memo to employees, founder Deepinder Goyal said the company was witnessing strong interest from external investors at a valuation of USD 500 million. He added that before Temple closed its next funding round, he wanted a part of the value created by the company to be shared with the employees who had helped build it. Wearable Product Pipeline
Goyal founded Temple after stepping down as chief executive officer of Eternal. The startup is developing a forehead-worn wearable device designed to monitor the body’s metabolic state in real time. The product is currently available through an early-access programme and is positioned as a wellness device.
According to media reports, the wearable is expected to be launched commercially within the next year, subject to further product validation and development. Temple has also been expanding its workforce and accelerating product development ahead of the wider rollout.
ESOP Buybacks Rise
Employee liquidity programmes have gathered pace across India’s startup ecosystem this year. According to a media report, nine startups have collectively undertaken ESOP buybacks worth more than USD 270 million in 2026. These include BrowserStack, Innovaccer, CoinDCX, Unacademy, Tractor Junction, Emversity, Cashfree Payments, Plum and Kratikal. More recently, travel fintech startup Scapia announced an ESOP buyback worth Rs 20 crore.
Temple’s latest valuation increase and its first ESOP liquidity programme reflect the company’s efforts to reward employees while advancing product development ahead of the commercial launch of its wellness wearable.
